Table 2.
C. urealyticum strain | Growth | Biofilm Formation | LNCaP Adhesion | HeLa Adhesion | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
a C+ | AHA | a C+ | AHA | a C+ | AHA | a C+ | AHA | |||||
b 0.25 | b 0.50 | b 0.25 | b 0.50 | b 0.50 | b 0.25 | b 0.25 | b 0.50 | |||||
ATCC 43042 | ++ | ++ | ++ | ++ | ++ | ++ | +++ | ++ | ++ | + | ++ | ++ |
ATCC 43043 | + | +++ | +++ | ++ | ++ | ++ | + | ++ | ++ | + | ++ | ++ |
ATCC 43044 | +++ | + | + | +++ | ++ | ++ | +++ | ++ | ++ | + | ++ | ++ |
a Control strains not treated with AHA. b Concentrations in mg/mL. + mild effect. ++ moderate effect. +++ strong effect.